> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-198/
- Published: 2018-10-07T12:00:00.000Z
- Updated: 2026-09-15T00:36:22.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142538

[**Docket No. Corrected on Dietary Supplement Notice**](https://www.fdaweb.com/docket-no-corrected-on-dietary-supplement-notice/)  
*Federal Register* notice: FDA corrects the docket number in a 9/7 Federal Register notice announcing a draft guidance entitled “Policy Regarding Quantitative Labeling of Dietary Supplements Containing Live Microbials.” 10/05/2018

[**Info Collection Extension Sought for User Fee Forms**](https://www.fdaweb.com/info-collection-extension-sought-for-user-fee-forms/)  
*Federal Register* notice: FDA submits to OMB an information collection extension for “Electronic User Fee Payment Request Forms — Form FDA 3913 and Form FDA 3914.” 10/05/2018

[**Joint Panel to Review ‘Abuse-deterrent’ Pain Drug**](https://www.fdaweb.com/joint-panel-to-review-abuse-deterrent-pain-drug/)  
*Federal Register* notice: FDA announces an 11/14 joint advisory committee meeting to discuss a SpecGx NDA for its abuse-deterrent pain drug. 10/05/2018

[**Comments Extended on Guide for Export Certificates**](https://www.fdaweb.com/comments-extended-on-guide-for-export-certificates/)  
*Federal Register* notice: FDA extends the comment period for a draft guidance entitled “Process To Request a Review of FDA’s Decision Not To Issue Certain Export Certificates for Devices.” 10/04/2018

[**Comments Sought on Info Collection for INDs**](https://www.fdaweb.com/comments-sought-on-info-collection-for-inds/)  
*Federal Register* notice: FDA seeks comments on an information collection extension entitled “Investigational New Drug Application—21 CFR Part 312.” 10/04/2018

[**CDRH Lists Guidance Docs for FY 2019**](https://www.fdaweb.com/cdrh-lists-guidance-docs-for-fy-2019/)  
*Federal Register* notice: FDA has announced the Web site location where it will post two lists of guidance documents that CDRH intends to publish in fiscal year 2019\. 10/04/2018

[**FDA, Canada Public Meeting on ICH Activities**](https://www.fdaweb.com/fda-canada-public-meeting-on-ich-activities/)  
*Federal Register* notice: FDA announces a 10/17 regional public meeting entitled “U.S. Food and Drug Administration and Health Canada Joint Public Consultation on International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use.” 10/04/2018

[**Guide on Drug Packaging and Labeling Terms**](https://www.fdaweb.com/guide-on-drug-packaging-and-labeling-terms/)  
*Federal Register* notice: FDA makes available a final guidance entitled “Selection of the Appropriate Package Type Terms and Recommendations for Labeling Injectable Medical Products Packaged in Multiple-Dose, Single-Dose, and Single-Patient-Use Containers for Human Use.” 10/03/2018

[**Draft Guide on ANDA Blocking Petitions**](https://www.fdaweb.com/draft-guide-on-anda-blocking-petitions/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act.” 10/03/2018